BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 21192023)

  • 1. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
    Wu ST; Ouyang Z; Olah TV; Jemal M
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a validated liquid chromatography tandem mass spectrometry assay for a PEGylated adnectin in cynomolgus monkey plasma using protein precipitation and trypsin digestion.
    Dawes ML; Gu H; Wang J; Schuster AE; Haulenbeek J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 934():1-7. PubMed ID: 23891912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery.
    Sleczka BG; D'Arienzo CJ; Tymiak AA; Olah TV
    Bioanalysis; 2012 Jan; 4(1):29-40. PubMed ID: 22191592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidinated protein internal standard for immunoaffinity-liquid chromatography/tandem mass spectrometry quantitation of protein therapeutics.
    Yang W; Kernstock R; Simmons N; Alak A
    Rapid Commun Mass Spectrom; 2014 Jul; 28(13):1489-500. PubMed ID: 24861599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma.
    Xu Y; Mehl JT; Bakhtiar R; Woolf EJ
    Anal Chem; 2010 Aug; 82(16):6877-86. PubMed ID: 20704377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
    Jemal M; Schuster A; Whigan DB
    Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
    Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
    Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated liquid-liquid extraction based on 96-well plate format in conjunction with ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) for the quantitation of methoxsalen in human plasma.
    Yadav M; Contractor P; Upadhyay V; Gupta A; Guttikar S; Singhal P; Goswami S; Shrivastav PS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):167-71. PubMed ID: 18656428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry.
    Flaherty JM; Connolly PD; Decker ER; Kennedy SM; Ellefson ME; Reagen WK; Szostek B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):329-38. PubMed ID: 15833298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monolithic-phase based on-line extraction approach for determination of pharmaceutical components in human plasma by HPLC-MS/MS and a comparison with liquid-liquid extraction.
    Naxing Xu R; Fan L; Kim GE; El-Shourbagy TA
    J Pharm Biomed Anal; 2006 Feb; 40(3):728-36. PubMed ID: 16289933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness.
    Jemal M; Ouyang Z
    Rapid Commun Mass Spectrom; 2003; 17(1):24-38. PubMed ID: 12478552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
    Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
    Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma.
    Jian W; Edom R; Weng N; Zannikos P; Zhang Z; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1687-99. PubMed ID: 20462810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS.
    Mao Y; Huang MQ; Xia YQ; Jemal M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1808-19. PubMed ID: 17236738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Al-Odaini NA; Zakaria MP; Yaziz MI; Surif S
    J Chromatogr A; 2010 Oct; 1217(44):6791-806. PubMed ID: 20851398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma.
    Xue YJ; Liu J; Pursley J; Unger S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):213-22. PubMed ID: 16388995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.